The hematopoietic microenvironment composed of stromal cells strictly regulates hematopoietic stem cells and hematopoietic progenitor cells by producing positive-and negative-regulators to supply mature hematopoietic cells to the periphery throughout its entire lifetime. However, hematopoiesis attenuates with aging. Extensive studies have revealed cellintrinsic deterioration of hematopoietic cells with aging, but the responsibility of the age-associated deterioration of stromal cells has not yet been fully elucidated. Senescence-accelerated mice (SAMP1) exhibited premature senescence-like stromal cell impairment after 30 weeks of age. Thus, this model mouse is a useful tool for clarifying the role of stromal cells during the development of senescence-associated defects in hematopoiesis. It is well known that B lymphopoiesis at steady-state is attenuated with aging, whereas myelopoiesis remains unaffected. At steady-state, SAMP1 mice exhibit simultaneous down-regulation of positive-and negative-regulators of B lymphopoiesis in the bone marrow during premature aging, resulting in suppressive homeostasis in B cell development. While both regulators are down-regulated, the relative cytokine levels are barely maintained at a steady-state. Once SAMP1 mice are in a perturbed condition induced by myeloablation or inflammation, the latent deterioration of stromal cell function becomes apparent in aged mice: they exhibit dysregulation of positive and negative regulators produced by stromal cells, resulting in decreased supportive activity for not only B lymphopoiesis, but also for the hematopoiesis of other lineages, such as myelopoiesis, erythropoiesis and mast cell development. These results suggest that the age-associated deterioration of hematopoiesis may be due not only to hematopoietic cell-intrinsic deterioration, but also to hematopoietic cell-extrinsic deterioration, such as stromal cell deterioration.
Introduction
Hematopoietic tissues, including the bone marrow and spleen, comprise two components, i.e., hematopoietic cells and non-hematopoietic cells; the latter cells make up the hematopoietic microenvironment. Hematopoietic stem cells (HSCs) have two cardinal functions: self-renewal and differentiation. HSCs are multipotent cells that can give rise to every kind of functional blood cell. Hematopoiesis in hematopoietic tissues is strictly regulated by stromal cells that make up the hematopoietic microenvironment and supply mature hematopoietic cells to the periphery throughout the entire lifetime. With aging, the lymphoid is reduced and hematopoietic cell component skewed toward myeloid, which suggests that homeostasis in the hematopoietic system changes with aging. This lymphoid vs. myeloid bias in hematopoiesis with aging is not only due to hematopoietic cell-intrinsic deterioration, but also to hematopoietic cell-extrinsic deterioration, such as stromal cell deterioration 1) . Although extensive studies have demonstrated cell-intrinsic deterioration in hematopoietic cells 2) , the responsibility of age-associated deterioration of stromal cells has not yet been fully elucidated because there has not been a good model mouse for investigating the age-related functional changes of stromal cells.
Recently, we demonstrated that senescence-accelerated mice (SAMP1) exhibit premature senescence-like stromal cell impairment after 30 weeks of age [3] [4] [5] [6] . As such, this model mouse is a useful tool for clarifying the role of stromal cells during the development of senescenceassociated defects in hematopoiesis. In this review, we focus on the age-related defects of stromal cell function in hematopoiesis using this model mouse.
Hematopoietic microenvironment
Schofield, in 1978, proposed a hypothesis in which the association of a stem cell with other cells determines its behavior, and it essentially becomes a fixed tissue cell 7) . The cellular environment that retains the stem cell is termed a "niche" 7) . A niche provides specific signals *Correspondence: tsuboi.isao@nihon-u.ac.jp for the maintenance of the quiescence and self-renewal capacity of HSCs. Although initial studies showed that HSCs are located in endosteal lesions, later studies have shown that HSCs are located in the sinusoid endothelium [8] [9] [10] . The location of HSCs in bone marrow has been controversial. A recent study has shown that HSCs and lineage-committed hematopoietic progenitor cells are localized near the endothelium with a predilection for the endosteal region 11) . Current evidence supports perivascular localization for most HSCs, with a predilection for the endosteal region 12) . Stromal cells comprising the hematopoietic microenvironment are a heterogeneous population consisting of macrophages, fibroblast cells, epithelial cells and fat cells, etc. Stromal cells strictly regulate the proliferation and differentiation of HSCs and hematopoietic progenitor cells by producing cytokines and by direct cellular interaction with adherent molecules [13] [14] [15] . Stromal cells produce not only positive regulators, but also negative regulators that maintain homeostasis in the hematopoietic system via the balance between the regulators. When young bone marrow cells were transplanted to young and old recipient mice, the homing efficiency of the HSCs was lower in the old recipient mice than in the young recipient mice 16) . Furthermore, the increased age of the HSC transplant recipient caused a marked skewing of the pattern of engraftment toward the myeloid lineage 16) . In addition, the generation of bone marrow pre-B cells and splenic B lymphocytes was impaired in irradiated old mice given bone marrow from young mice 17) . These data suggested that the function of the microenvironment may also become impaired with aging, and that this is attributed, in part, to the age-related deterioration of hematopoiesis.
Age-related changes in hematopoiesis of SAMP1 mice at steady state As age-related deterioration of hematopoiesis in humans is latent at steady state, decreases in the number of red blood cells, white blood cells and platelets in healthy elderly individuals are slight, and do not impose any disadvantage to their ordinary life. However, it was recently reported that aged human HSCs exhibited myeloid-biased differentiation potential and a significantly diminished capacity to give rise to lymphoid B lineage cells when compared with young HSCs 18) . Fig. 1 19) . Steady-state B lymphopoiesis in humans and mice is attenuated with aging, whereas myelopoiesis remains unchanged [18] [19] [20] [21] . As such, it is likely that lymphoid lineages are more sensitive to the effects of aging than myeloid lineages.
Stromal cells produce not only positive regulators of B lymphopoiesis, such as interleukin (IL)-7, but also negative regulators, such as transforming growth factor-beta (TGF-β). Interestingly, it has been reported that IL-7 and TGF-β share a reciprocal relationship with each other 22, 23) ; each can down-regulate the gene expression of the other. It is postulated that, in the case of accelerated B lymphopoiesis, there is a simultaneous up-regulation of IL-7 production and down-regulation of TGF-β production in stromal cells; in contrast, in the case of decelerated B lymphopoiesis, there is a simultaneous up-regulation of TGF-β production and down-regulation of IL-7 production in stromal cells 24) . The IL-7 produced by stromal cells is a crucial factor for B-cell development and non-redundant cytokines 25) . B lymphopoiesis in the bone marrow of IL-7 gene-deleted mice was blocked at the transition from the pro-B to pre-B cell stages, which is phenotypically similar to the decrease in B lymphopoiesis in aged mice 25) . Furthermore, it was reported that, in long-term bone marrow cultures for B lymphopoiesis, the production and release of IL-7 by stromal cells was impaired with aging, resulting in decreased supportive activity for B lymphopoiesis 26, 27) . Thus, decreased B lymphopoiesis with aging has been considered to be due to decreased IL-7 production by stromal cells. Interestingly, in SAMP1 mice, in addition to the previously reported decrease in IL-7 production by aged stromal cells 26, 27) , the production of TGF-β by aged stromal cells also decreased when compared to that of young stromal cells. Both IL-7 and TGF-β production by stromal cells at steady state decreased with aging, which implied that senescent B lymphopoiesis is "balanced in suppressive homeostasis" (Fig. 2) 6) . It seems likely that the decrease in B lymphopoiesis with aging is the result of an overall decrease in the levels of regulatory cytokines that drive the process, rather than active suppression by an increase in TGF-β or a decrease in IL-7 with age.
Age-related changes in hematopoietic responses to myeloablation in SAMP1 mice
Aging of the immune system, which is termed "immunosenescence", is characterized by a time-dependent functional decline of immunity. The complex process of immunosenescence affects both the innate and adaptive arms of the immune system 28, 29) . B cells are crucial effector cells that play a key role in adaptive immunity. B lymphopoiesis at steady state is regulated by low-level cytokine secretions with minimal changes. Additionally, there is a reservoir of cytokines that is sufficient for maintaining steady-state B lymphopoiesis. Thus, age-related changes in stromal cell function during B lymphopoiesis is latent at steady state. However, aged mice exposed to myeloablation, induced by an anticancer drug, disclosed age-related deterioration of stromal cell function due to its increase to supply sufficient mature hematopoietic cells on demand.
When 5-fluorouracil (5-FU), a myeloablative agent, was intravenously injected into young and aged SAMP1 mice, there was no difference in the recovery process of CFU-GM between the young and aged mice (Fig. 3A) 30) . In contrast to the myeloid lineage, the recovery process of CFU-preB was markedly different between young and aged mice: the young mice experienced a high recovery rate of 60% of the pretreatment levels, whereas the aged mice showed a low recovery rate of only 20% of the pretreatment levels (Fig. 3B ) 30) . These results are compatible with those observed in a conventional mouse strain 31) . Fig.  3C and 3D show the time course of the gene expression levels of regulators for B lymphopoiesis, such as stromal cell-derived factor-1 (SDF-1), a positive regulator, and tumor necrosis factor-alpha (TNF-α), a negative regulator, in young and aged mice after treatment with 5-FU 30) . It has been reported that the SDF-1 and TNF-α produced by stromal cells also share a reciprocal relationship with each other, and that TNF-α can down-regulate the gene expression of SDF-1 32) . Interestingly, changes in the gene expression levels of SDF-1 and TNF-α in young and aged mice are reciprocal to each other ( Fig. 3C and 3D) . After day 7, the gene expression of SDF-1 and TNF-α in young mice tended to return to a steady-state level (Fig.  3C ), but in aged mice, TNF-α remained up-regulated and SDF-1 remained reciprocally down-regulated (Fig. 3D) . The suppression of B-cell progenitor cells in aged mice treated with 5-FU may be, in part, due to the prolonged up-regulation of a negative regulator, such as TNF-α, and concomitant down-regulation of a positive regulator, such as SDF-1.
Mast cells are also crucial effector cells that play a key role in innate immunity 33) . Mast cells, like other immune component cells, such as T cells, B cells and macrophages, are derived from hematopoietic stem cells. When 5-FU was intravenously injected into young and aged SAMP1 mice, the aged mice showed a lower recovery of the number of femoral mast cell progenitors (CFU-mast: 64% of steady state), whereas the young mice showed a higher recovery (122% of steady state) (Fig. 4A ) 34) . Mast cell development in the bone marrow is regulated by stromal cells, which produce positive regulators, such as stem cell factor (SCF), and negative regulators, such as TGF-β. The ratio of the gene expression of SCF to that of TGF-β (SCF/TGF-β ratio) indicates the balance between the positive and negative regulators of mast cell development. The SCF/TGF-β ratio increased in both young and aged mice after 5-FU treatment, implying that mast cell development is promoted by stromal cells (Fig. 4B and 4C ) 34) . Subsequently, however, the SCF/TGF-β ratio rapidly decreased in aged mice (Fig. 4C) , whereas it remained high in young mice (Fig. 4B) . These results suggest that mast cell development declines with aging due to the functional impairment of stromal cells, which contributes to immunosenescence.
Age-related changes in hematopoietic responses to inflammation in SAMP1 mice
When an infection occurs in humans and mice, myelopoiesis is promoted, but erythropoiesis is suppressed. Neutrophils and macrophages are crucial effector cells that play a key role in innate immunity during acute infection. Attenuation of myelopoietic responses to infection 
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Differentiation of B cell progenitor and of neutrophil functions against pathogens increases morbidity and mortality among the elderly [35] [36] [37] . In addition, anemia is a common multifocal condition among the elderly 38) . When infection and inflammation occur in elderly individuals with slight anemia, their anemia becomes exacerbated, which results in an increased risk of adverse events.
Neopterin produced by monocytes during infection and inflammation promotes myelopoiesis, but suppresses erythropoiesis by activating stromal cells in mice 39, 40) . Thus, neopterin is a useful agent for investigating the age-related functional changes of stromal cells for hematopoiesis during infection and inflammation 41, 42) . When neopterin was intravenously injected into young and aged SAMP1 mice, the aged SAMP1 mice showed a limited increase in the number of femoral CFU-GM (Fig. 5B) , whereas the young SAMP1 mice showed a marked increase in the number of femoral CFU-GM (Fig. 5A ) 43) . When treated with neopterin, the gene expression levels of granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-6, which are positive regulators of myelopoiesis produced by stromal cells, were both markedly up-regulated and remained high thereafter in young mice, but not in aged mice 43) . These results suggest that the agerelated poor myelopoietic response to infection and inflammation is due to the functional impairment of stromal cells in the bone marrow.
When neopterin was intravenously injected into young and aged SAMP1 mice, the aged SAMP1 mice showed a decrease in the number of erythroid progenitor cells (BFU-E and CFU-E) for 3 weeks (Fig. 5B) ; in contrast, the young SAMP1 mice showed a decrease in the number of erythroid progenitor cells for only 1 week (Fig. 5A ) 43) . The gene expression of TNF-α, a negative regulator of erythropoiesis, was up-regulated to the same degree in the bone marrow of both young and aged mice (Fig. 5C  and 5D ). The gene expression of IL-11, a positive regulator of erythropoiesis, was also up-regulated over 1 day in both the young and aged mice. Subsequently, however, IL-11 gene expression was rapidly down-regulated in aged mice (Fig. 5D) , whereas it remained up-regulated in young mice (Fig. 5C ). These data suggest that the prolonged suppression of erythropoiesis in aged mice may be due to a decrease in the production of positive regulators, rather than to an increase in the production of negative regulators. esis latently deteriorates with aging in mice, resulting in senescent hematopoiesis at a steady state that is "balanced in suppressive homeostasis". When exposed to stresses, such as myeloablation or inflammation, the latent deterioration of stromal cell function can be seen in aged mice, and this deterioration can increase the severity of infectious diseases and anemia. The progressive shortening of telomeres, oxidative stress, epigenetic changes and DNA damage are considered to be the causes of the deterioration of stromal cell function with aging 44, 45) . Further study is required to clarify the mechanisms underlying the agerelated changes in stromal cell function.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this article.
Categories of typical age-related changes in cytokine gene expression by stromal cells in response to stresses, such as myeloablation and inflammation
Age-related changes in cytokine gene expression by stromal cells in response to stresses, such as myeloablation and inflammation, are categorized into four patterns.
Patterns 1 and 2 involve myeloablation induced by 5-FU. In the first typical pattern (Fig. 6A vs. Fig. 6B ), the cytokine gene expression level of stromal cells after myeloablation was up-regulated in both young and aged mice. However, the level of the cytokines oscillated in the aged mice rather than remaining at a high level (Fig. 6B) , whereas the level remained high in the young mice (Fig.  6A ). This pattern was observed for GM-CSF, IL-6 and SCF in the bone marrow after 5-FU treatment 30, 34) . In the second typical pattern (Fig. 6C vs. 6D) , the cytokine gene expression level of stromal cells after myeloablation was up-regulated in both young and aged mice. The cytokine gene expression level in young mice was promptly down-regulated and quickly returned to pretreatment levels (Fig. 6C) . However, the cytokine gene expression level in aged mice was only temporarily downregulated, and was up-regulated again and remained high thereafter (Fig. 6D ). This pattern was observed for TNF-α in the bone marrow after 5-FU treatment 30) . Patterns 3 and 4 involve inflammation induced by neopterin. In the third typical pattern (Fig. 6E vs. Fig. 6F ), the cytokine gene expression level of stromal cells after inflammation was up-regulated in both young and aged mice. However, the cytokine gene expression level in aged mice was rapidly down-regulated to pretreatment levels (Fig. 6F) , whereas that in young mice remained high thereafter (Fig. 6E ). This pattern was observed for IL-6 and IL-11 in the bone marrow after neopterin treatment 43) . In the fourth typical pattern (Fig. 6G vs. Fig. 6H ), the cytokine gene expression level in young mice after inflammation was up-regulated and remained high thereafter (Fig. 6G) . However, the cytokine gene expression level in aged mice after inflammation remained unchanged (Fig. 6H ). This pattern was observed for GM-CSF in the bone marrow after neopterin treatment 43) . These age-related typical changes in cytokine gene expression by stromal cells in response to stresses caused an imbalance between the positive and negative regulators; as a result, the hematopoietic tissues were eventually unable to supply sufficient mature hematopoietic cells on demand.
Conclusions
Stromal cells comprising the hematopoietic microenvironment control hematopoiesis by maintaining the appropriate balance between positive and negative regulators on demand. The function of stromal cells in hematopoi-
